This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Mar;15(3):232-3.

doi: 10.1016/S1474-4422(16)00003-X. Epub 2016 Jan 13.

Acetylcholinesterase inhibitors and gait: a steadying hand?

Caroline Moreau¹, David Devos², Luc Defebvre²

Affiliations

Affiliations

¹ Service de Neurologie et Pathologie du mouvement, Pole de Neurosciences et Appareil Locomoteur, Hôpital Roger Salengro, CHRU de Lille, INSERM UMR 1171, Université de Lille 2, Lille, France. Electronic address: caroline.moreau@chru-lille.fr.
² Service de Neurologie et Pathologie du mouvement, Pole de Neurosciences et Appareil Locomoteur, Hôpital Roger Salengro, CHRU de Lille, INSERM UMR 1171, Université de Lille 2, Lille, France.

PMID: 26795875
DOI: 10.1016/S1474-4422(16)00003-X

Free article

Comment

Acetylcholinesterase inhibitors and gait: a steadying hand?

Caroline Moreau et al. Lancet Neurol. 2016 Mar.

Free article

. 2016 Mar;15(3):232-3.

doi: 10.1016/S1474-4422(16)00003-X. Epub 2016 Jan 13.

Authors

Caroline Moreau¹, David Devos², Luc Defebvre²

Affiliations

¹ Service de Neurologie et Pathologie du mouvement, Pole de Neurosciences et Appareil Locomoteur, Hôpital Roger Salengro, CHRU de Lille, INSERM UMR 1171, Université de Lille 2, Lille, France. Electronic address: caroline.moreau@chru-lille.fr.
² Service de Neurologie et Pathologie du mouvement, Pole de Neurosciences et Appareil Locomoteur, Hôpital Roger Salengro, CHRU de Lille, INSERM UMR 1171, Université de Lille 2, Lille, France.

PMID: 26795875
DOI: 10.1016/S1474-4422(16)00003-X

No abstract available

PubMed Disclaimer

Comment on

Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial.
Henderson EJ, Lord SR, Brodie MA, Gaunt DM, Lawrence AD, Close JC, Whone AL, Ben-Shlomo Y. Henderson EJ, et al. Lancet Neurol. 2016 Mar;15(3):249-58. doi: 10.1016/S1474-4422(15)00389-0. Epub 2016 Jan 13. Lancet Neurol. 2016. PMID: 26795874 Clinical Trial.

Similar articles

Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial.
Henderson EJ, Lord SR, Brodie MA, Gaunt DM, Lawrence AD, Close JC, Whone AL, Ben-Shlomo Y. Henderson EJ, et al. Lancet Neurol. 2016 Mar;15(3):249-58. doi: 10.1016/S1474-4422(15)00389-0. Epub 2016 Jan 13. Lancet Neurol. 2016. PMID: 26795874 Clinical Trial.
[Rivastigmine and Parkinson's disease without dementia : Impact on gait stability and frequency of falling].
Amadori K. Amadori K. Z Gerontol Geriatr. 2016 Oct;49(7):662-663. doi: 10.1007/s00391-016-1130-1. Z Gerontol Geriatr. 2016. PMID: 27599816 Clinical Trial. German. No abstract available.
Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study.
Mamikonyan E, Xie SX, Melvin E, Weintraub D. Mamikonyan E, et al. Mov Disord. 2015 Jun;30(7):912-8. doi: 10.1002/mds.26236. Epub 2015 Apr 25. Mov Disord. 2015. PMID: 25914281 Clinical Trial.
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.
Kandiah N, Pai MC, Senanarong V, Looi I, Ampil E, Park KW, Karanam AK, Christopher S. Kandiah N, et al. Clin Interv Aging. 2017 Apr 18;12:697-707. doi: 10.2147/CIA.S129145. eCollection 2017. Clin Interv Aging. 2017. PMID: 28458525 Free PMC article. Review.
The pharmacologic treatment of gait ignition failure.
Rascol O, Fabre N, Brefel-Courbon C, Montastruc JL. Rascol O, et al. Adv Neurol. 2001;87:255-64. Adv Neurol. 2001. PMID: 11347230 Review. No abstract available.

See all similar articles

Cited by

Salivary biomarkers for the diagnosis and monitoring of neurological diseases.
Farah R, Haraty H, Salame Z, Fares Y, Ojcius DM, Said Sadier N. Farah R, et al. Biomed J. 2018 Apr;41(2):63-87. doi: 10.1016/j.bj.2018.03.004. Epub 2018 May 10. Biomed J. 2018. PMID: 29866603 Free PMC article. Review.
Gait, posture and cognition in Parkinson's disease.
Barbosa AF, Chen J, Freitag F, Valente D, Souza CO, Voos MC, Chien HF. Barbosa AF, et al. Dement Neuropsychol. 2016 Oct-Dec;10(4):280-286. doi: 10.1590/s1980-5764-2016dn1004005. Dement Neuropsychol. 2016. PMID: 29213470 Free PMC article. Review.
Movement disorders associated with acetylcholinesterase inhibitors in Alzheimer's dementia: A systematic review.
Rissardo JP, Caprara ALF. Rissardo JP, et al. Brain Circ. 2025 Mar 21;11(1):9-23. doi: 10.4103/bc.bc_134_24. eCollection 2025 Jan-Mar. Brain Circ. 2025. PMID: 40224553 Free PMC article. Review.
Managing Gait, Balance, and Posture in Parkinson's Disease.
Debû B, De Oliveira Godeiro C, Lino JC, Moro E. Debû B, et al. Curr Neurol Neurosci Rep. 2018 Apr 6;18(5):23. doi: 10.1007/s11910-018-0828-4. Curr Neurol Neurosci Rep. 2018. PMID: 29623455 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information